OncoCyte Corp (OCX) — Financial Flexibility Index
OncoCyte Corp (OCX) has a Financial Flexibility Index of -0.11x as of March 2025. Free cash flow of $-5.55 Million (operating CF $-5.86 Million minus capex $307.00K) represents 0% of total liabilities ($50.14 Million). Check OncoCyte Corp total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OncoCyte Corp Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for OncoCyte Corp across 12 annual periods. For the full cash flow conversion analysis, see how efficiently does OncoCyte Corp generate cash.
Annual Financial Flexibility Index for OncoCyte Corp (2013–2024)
Year-by-year free cash flow to debt coverage for OncoCyte Corp. Explore OCX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.43x | $-20.20 Million | $-20.71 Million | $47.35 Million | ▲ +8.8% |
| 2023 | -0.47x | $-23.04 Million | $-23.32 Million | $49.30 Million | ▲ +25.4% |
| 2022 | -0.63x | $-41.23 Million | $-45.57 Million | $65.80 Million | ▼ -75.4% |
| 2021 | -0.36x | $-33.69 Million | $-35.94 Million | $94.35 Million | ▲ +68.4% |
| 2020 | -1.13x | $-24.75 Million | $-25.98 Million | $21.94 Million | ▲ +45.8% |
| 2019 | -2.08x | $-18.80 Million | $-19.71 Million | $9.02 Million | ▼ -9.3% |
| 2018 | -1.91x | $-11.62 Million | $-11.65 Million | $6.09 Million | ▲ +16.7% |
| 2017 | -2.29x | $-13.29 Million | $-13.38 Million | $5.81 Million | ▼ -41.4% |
| 2016 | -1.62x | $-7.42 Million | $-7.52 Million | $4.58 Million | ▼ -0.4% |
| 2015 | -1.61x | $-3.73 Million | $-4.23 Million | $2.31 Million | ▼ -936.7% |
| 2014 | -0.16x | $-1.16 Million | $-1.16 Million | $7.43 Million | ▼ -6.0% |
| 2013 | -0.15x | $-685.00K | $-710.00K | $4.67 Million | — |